Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate the Safety of Reducing Dual Antiplatelet Therapy (DAPT) Duration to 1 Month for Patients With Acute Coronary Syndrome (ACS) After Implantation of Everolimus-eluting Cobalt-chromium Stent

NCT03462498 is registered in ClinicalTrials.gov with Kyoto University, Graduate School of Medicine as lead sponsor.

NCT NCT03462498
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03462498 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate the Safety of Reducing Dual Antiplatelet Therapy (DAPT) Duration to 1 Month for Patients With Acute Coronary Syndrome (ACS) After Implantation of Everolimus-eluting Cobalt-chromium Stent
Lead sponsor
Kyoto University, Graduate School of Medicine
Phase
Phase 4
Overall status
Unknown status
Start date
April 2, 2018
Completion date
March 31, 2026
Enrollment
3,008 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, acute myocardial infarction, coronary artery disease, percutaneous coronary intervention, platelet aggregation inhibitors